Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia
Data up to Jan 2025
Total Citations Per Year
Abstract
References (47)
The AIDS dementia complex: II. Neuropathology
1986 • 1,280 citations
Striatal dopamine nerve terminal markers in human, chronic methamphetamine users
1996 • 715 citations
Drug dependence: stress and dysregulation of brain reward pathways
1998 • 652 citations
Biochemical aspects of Parkinson's disease
1998 • 532 citations
Dendritic injury is a pathological substrate for human immunodeficiency virus—related cognitive disorders
1997 • 470 citations
HIV-1 Protein Tat Induces Apoptosis of Hippocampal Neurons by a Mechanism Involving Caspase Activation, Calcium Overload, and Oxidative Stress
1998 • 400 citations
Evidence for Synaptic Apoptosis
1998 • 342 citations
Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic
1996 • 310 citations
Cortical Synaptic Density is Reduced in Mild to Moderate Human Immunodeficiency Virus Neurocognitive Disorder
1999 • 289 citations
Human immunodeficiency virus type 1 tat activates non—N‐methyl‐<scp>D</scp>‐aspartate excitatory amino acid receptors and causes neurotoxicity
1995 • 277 citations
Under Siege: The Brain on Opiates
1996 • 263 citations
Amyloid β-peptide induces apoptosis-related events in synapses and dendrites
1998 • 254 citations
Neurobiological aspects of human immunodeficiency virus infection:Neurotoxic mechanisms
1998 • 231 citations
Cortical dendritic pathology in human immunodeficiency virus encephalitis.
1992 • 194 citations
Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users
1996 • 168 citations
Opiates as potential cofactors in progression of HIV-1 infections to AIDS
1998 • 158 citations
Opioid receptor-mediated inhibition of dopamine and acetylcholine release from slices of rat nucleus accumbens, olfactory tubercle and frontal cortex
1990 • 157 citations
Intraventricular Injection of Human Immunodeficiency Virus Type 1 (HIV-1) Tat Protein Causes Inflammation, Gliosis, Apoptosis, and Ventricular Enlargement
1998 • 153 citations
Extrapyramidal symptoms due to dopamine-blocking agents in patients with AIDS encephalopathy
1991 • 148 citations
Cerebrospinal fluid dopamine in HIV-1 infection
1994 • 147 citations
HIV Dementia and the Basal Ganglia
1997 • 125 citations
Dopamine deficits in the brain
1996 • 123 citations
HIV Infection of Human Choroid Plexus
1995 • 115 citations
Neurotoxicity of peptide analogues of the transactivating protein tat from maedi-visna virus and human immunodeficiency virus
1993 • 111 citations
Exogenous tat protein activates central nervous system-derived endothelial cells
1994 • 96 citations
HIV-1 gp120-induced neurotoxicity to midbrain dopamine cultures
1995 • 95 citations
Prostate Apoptosis Response‐4 Production in Synaptic Compartments Following Apoptotic and Excitotoxic Insults
1999 • 94 citations
Polymorphisms of the dopamine D 4 receptor and response to antipsychotic drugs
1999 • 81 citations
Sodium Valproate, an Anticonvulsant Drug, Stimulates Human Immunodeficiency Virus Type 1 Replication Independently of Glutathione Levels
1996 • 78 citations
HIV-1 Proviral DNA Load Across Neuroanatomic Regions of Individuals With Evidence for HIV-1-Associated Dementia
1997 • 75 citations
Cerebrospinal fluid catecholamine metabolites in HIV‐infected patients
1991 • 71 citations
Evidence that Par-4 Participates in the Pathogenesis of HIV Encephalitis
1999 • 69 citations
Pilot study with clozapine in patients with HIV-associated psychosis and drug-induced parkinsonism
1999 • 63 citations
Neuropathogenesis of Chimeric Simian/Human Immunodeficiency Virus infection In Pig-tailed and Rhesus Macaques
1997 • 55 citations
Regulation of glutathione and cell toxicity following exposure to neurotropic substances and human immunodeficiency virus-1in vitro
1997 • 45 citations
Cell Type-Dependent Effect of Sodium Valproate on Human Immunodeficiency Virus Type 1 Replicationin Vitro
1997 • 43 citations
Valpoic acid reduces the intracellular level of glutathione and stimulates human immunodeficiency virus
1994 • 40 citations
Levodopa therapy improves motor function in HIV-infected children with extrapyramidal syndromes
1996 • 39 citations
Opioids Disrupt Ca2+Homeostasis and Induce Carbonyl Oxyradical Production in Mouse Astrocytesin Vitro:Transient Increases and Adaptation to Sustained Exposure
1998 • 38 citations
Tryptophan Concentrations Increase in Cerebrospinal Fluid and Blood after Zidovudine Treatment in Patients with HIV Type 1 Infection
1994 • 38 citations
Monoamine metabolite levels in CSF of SIV-infected rhesus monkeys (Macaca mulatta)
1997 • 30 citations
Metabolites of the antipsychotic agent clozapine inhibit the replication of human immunodeficiency virus type 1
1997 • 30 citations
Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine‐related drugs on rat midbrain dopaminergic neurons
1999 • 21 citations
Inhibition of human immunodeficiency virus type 1 replication and cytopathicity by synthetic soluble catecholamine melanins in vitro
1990 • 19 citations
Increased dopamine receptor sensitivity in the rat following acute administration of sufentanil, U50,488H and d-Ala2-d-Leu5-enkephalin
1991 • 18 citations
Intermittent morphine administration induces a long-lasting synergistic effect of corticosterone on dopamine D1 receptor functioning in rat striatal GABA neurons
1997 • 18 citations
High signal intensity of both putamina in patients with HIV infection
1991 • 12 citations